Located at the heart of the third largest European university hospital center, Marseille Medical Genetics (MMG) boasts a triple mission: decipher the mechanisms involved in genetic diseases, open new diagnostic and therapeutic pathways and improve the quality of life of patients affected by these rare diseases.
From the genetics of rare diseases to developmental biology, from epigenetics to genome dynamics and from bioinformatics to systems biology, the MMG explores all facets of the discipline through a translational approach that focuses on the patient.
One hundred and fifty researchers, clinicians, engineers, post docs and students seek to improve our knowledge of these diseases by combining the exploration of patient cohorts and pathophysiological models using state-of-the-art technologies within five platforms.
Closely associated with the Department of Medical Genetics of the Timone Hospital, the MMG is a joint research unit of Inserm and Aix-Marseille University. Led by Professor Nicolas LEVY, the MMG is also one of the founding members of MaRCHE, the university hospital federation dedicated to rare diseases, which is certified by A*MIDEX University Foundation, AP-HM and the Alliance des Sciences de la Vie et de la Santé.